country

Change Language

EN - English
FR - Français
DE - Deutsch
ES - Español
JA - 日本語
KO - 한국어

Country or Region:

United States

Product Name	Size / Unit Price	Qty

Total: USD 0.00 Checkout

91 Results for "

LNCAP

" in MedChemExpress (MCE) Product Catalog:

Products (91)

Sort by :

Categories

By Targets

Products

246

Enzalutamide

246 Publications Verification

Cat. No.: HY-70002

CAS No.: 915087-33-1

Synonyms: MDV3100

Target:

Androgen Receptor Autophagy

Research Areas:

Cancer

Enzalutamide (MDV3100) is an androgen receptor (AR) antagonist with an IC₅₀ of 36 nM in LNCaP prostate cells. Enzalutamide is an autophagy activator .

Compare

Please select quantity

August 31

Get Quote

View All Sizes

AZD3514

3 Cited Publications

Cat. No.: HY-16079

CAS No.: 1240299-33-5

Target:

Androgen Receptor

Research Areas:

Cancer

AZD3514 is an orally activie and selective androgen receptor (AR) inhibitor. AZD3514 androgen-dependently and -independently inhibits AR signal. AZD351 down-regulates nuclear AR levels in human LNCaP prostate cancer cells in the absence of androgen with an pIC₅₀ value of 5.75. AZD3514 can be used for the research of prostate cancer .

Compare

Please select quantity

August 31

Get Quote

View All Sizes

Atraric acid

1 Cited Publications

Cat. No.: HY-N2908

CAS No.: 4707-47-5

Synonyms: Methyl atrarate

Category:

Microorganisms Essence, Fragrance Phenols Cosmetic Research Plants Disease Research Fields Inflammation/Immunology Cancer

Target:

Environmental Pollutants NF-κB Androgen Receptor p38 MAPK NO Synthase

Atraric acid (Methyl atrarate) is a specific androgen receptor (AR) antagonist with anti-inflammatory and anticancer effects. Atraric acid represses the expression of the endogenous prostate specific antigen gene in both LNCaP and C4-2 cells. Atraric acid can also inhibit the synthesis of NO and cytokine, and suppress the MAPK-NFκB signaling pathway. Atraric acid can be used to research prostate diseases and inflammatory diseases .

Compare